Pharmacokinetic and Pharmacodynamic Interaction between Allopurinol and Probenecid??in Healthy Subjects
Sophie L. Stocker(University of California, San Francisco), Richard O. Day(St Vincent's Hospital Sydney), Garry G. Graham(UNSW Sydney), Andrew J. McLachlan(The University of Sydney), Kenneth M. Williams(UNSW Sydney)
Cited by 37
Related Papers
Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes
|Journal of Clinical Epidemiology|2012|1.2k
Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis
|BMJ Open|2016|527
Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies
|Thrombosis and Haemostasis|2014|467
Clinical Pharmacokinetics and Pharmacodynamics of Celecoxib
|Clinical Pharmacokinetics|2000|424